Skip to search formSkip to main contentSkip to account menu

Algammulin

Known as: gamma-inulin - alum, gamma-inulin-adsorbed alum 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (4)

Alum CompoundsDrug CombinationsImmunologic AdjuvantsInulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
Vaccine‐Induced Th1‐Type Responses are Dominant over Th2‐Type Responses in the Short Term whereas Pre‐existing Th2 Responses are Dominant in the Longer Term
The effect of adjuvant on induction of human papillomavirus type 16 E7 protein‐specific cytotoxic T lymphocytes (CTL) and… 
1998
1998
Influence of several adjuvants on the immune response against a recombinant meningococcal high molecular weight antigen.
Studying outer membrane proteins as vaccine candidates, our group has previously isolated, cloned, and expressed in Escherichia… 
1996
1996
Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
Review
1995
Review
1995
Vaccine adjuvants based on gamma inulin.
Algammulin and gamma-IN comprise a novel class of vaccine adjuvant. Their use in vaccines is to exploit the humoral defense known… 
1995
1995
The influence of gamma inulin and Algammulin on the immune response in sheep to a recombinant antigen of Taenia ovis.
Highly Cited
1992
Highly Cited
1992
Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.
Three octapeptides from the N and C terminal C regions of the merozoite surface Ag 2 (MSA2) of Plasmodium falciparum elicit anti… 
Highly Cited
1991
Highly Cited
1991
The adjuvanticity of Algammulin, a new vaccine adjuvant.
1991
1991
Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.
1991
1991
Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice.
1991
1991
High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2.
We have identified a 51-kDa glycosylated myristoylated merozoite surface antigen as the target of a number of monoclonal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)